Belpointe Asset Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.35M | Sell |
14,877
-88
| -0.6% | -$8.07K | 0.05% | 351 |
|
|
2025
Q4 | $1.35M | Buy |
14,965
+230
| +2% | +$21.8K | 0.05% | 331 |
|
|
2025
Q3 | $1.45M | Buy |
14,735
+1,300
| +10% | +$129K | 0.06% | 297 |
|
|
2025
Q2 | $1.23M | Sell |
13,435
-1
| -0% | -$97 | 0.05% | 299 |
|
|
2025
Q1 | $1.52M | Sell |
13,436
-101
| -0.7% | -$10.8K | 0.08% | 240 |
|
|
2024
Q4 | $1.56M | Hold |
13,537
| – | – | 0.09% | 210 |
|
|
2024
Q3 | $1.46M | Sell |
13,537
-249
| -2% | -$27.2K | 0.09% | 227 |
|
|
2024
Q2 | $1.5M | Sell |
13,786
-137
| -1% | -$16.1K | 0.1% | 192 |
|
|
2024
Q1 | $1.84M | Buy |
13,923
+61
| +0.4% | +$7.62K | 0.14% | 141 |
|
|
2023
Q4 | $1.69M | Sell |
13,862
-218
| -2% | -$24.3K | 0.15% | 138 |
|
|
2023
Q3 | $1.58M | Buy |
14,080
+225
| +2% | +$28.6K | 0.16% | 126 |
|
|
2023
Q2 | $2.02M | Buy |
13,855
+3,618
| +35% | +$492K | 0.21% | 96 |
|
|
2023
Q1 | $1.32M | Sell |
10,237
-4,628
| -31% | -$581K | 0.07% | 278 |
|
|
2022
Q4 | $1.9M | Sell |
14,865
-95
| -0.6% | -$11K | 0.11% | 182 |
|
|
2022
Q3 | $1.56M | Buy |
14,960
+67
| +0.4% | +$7.35K | 0.11% | 205 |
|
|
2022
Q2 | $1.56M | Sell |
14,893
-39
| -0.3% | -$4.63K | 0.1% | 209 |
|
|
2022
Q1 | $1.91M | Sell |
14,932
-2,079
| -12% | -$251K | 0.12% | 181 |
|
|
2021
Q4 | $2.1M | Buy |
17,011
+251
| +1% | +$32.9K | 0.13% | 153 |
|
|
2021
Q3 | $2.38M | Buy |
16,760
+2,705
| +19% | +$398K | 0.16% | 130 |
|
|
2021
Q2 | $2.19M | Buy |
14,055
+155
| +1% | +$25.1K | 0.16% | 137 |
|
|
2021
Q1 | $2.16M | Sell |
13,900
-7,131
| -34% | -$1.1M | 0.18% | 118 |
|
|
2020
Q4 | $3.15M | Buy |
21,031
+6,412
| +44% | +$906K | 0.28% | 73 |
|
|
2020
Q3 | $1.93M | Sell |
14,619
-5
| -0% | -$653 | 0.22% | 101 |
|
|
2020
Q2 | $1.7M | Sell |
14,624
-8
| -0.1% | -$922 | 0.22% | 95 |
|
|
2020
Q1 | $1.44M | Buy |
14,632
+78
| +0.5% | +$10.2K | 0.25% | 92 |
|
|
2019
Q4 | $2.12M | Buy |
14,554
+41
| +0.3% | +$5.66K | 0.27% | 94 |
|
|
2019
Q3 | $1.93M | Buy |
14,513
+204
| +1% | +$26.4K | 0.31% | 77 |
|
|
2019
Q2 | $1.64M | Buy |
14,309
+12
| +0.1% | +$1.41K | 0.32% | 67 |
|
|
2019
Q1 | $1.77M | Buy |
14,297
+75
| +0.5% | +$8.52K | 0.35% | 49 |
|
|
2018
Q4 | $1.43M | Buy |
14,222
+109
| +0.8% | +$12.3K | 0.36% | 58 |
|
|
2018
Q3 | $1.8M | Buy |
14,113
+67
| +0.5% | +$7.97K | 0.28% | 66 |
|
|
2018
Q2 | $1.52M | Hold |
14,046
| – | – | 0.42% | 33 |
|
|
2018
Q1 | $1.49M | Sell |
14,046
-117
| -0.8% | -$13.6K | 0.43% | 32 |
|
|
2017
Q4 | $1.66M | Buy |
14,163
+86
| +0.6% | +$9.72K | 0.36% | 53 |
|
|
2017
Q3 | $1.6M | Buy |
+14,077
| New | +$1.62M | 0.37% | 56 |
|
Other funds holding ZBH
VCM
VPM
Belpointe Asset Management's ZBH Position: Q1 2026 in Review
Belpointe Asset Management reduced its Zimmer Biomet (ZBH) stake by 0.59% in Q1 2026, selling an estimated $8.07K and leaving 14,877 shares worth $1.35M. The position accounts for 0.05% of the portfolio, ranked #351.
Belpointe Asset Management first reported a position in ZBH in Q3 2017 and has held it in 35 quarters since. The position peaked at $3.15M in Q4 2020. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Belpointe Asset Management held 14,877 shares of Zimmer Biomet worth $1.35M as of Q1 2026.
- Belpointe Asset Management sold 88 Zimmer Biomet shares in Q1 2026, an estimated $8.07K.
- Zimmer Biomet made up 0.05% of Belpointe Asset Management's portfolio in Q1 2026, its #351 holding.
- Belpointe Asset Management first reported a position in Zimmer Biomet in Q3 2017 and has held it in 35 quarters since.
- Belpointe Asset Management's Zimmer Biomet position peaked at $3.15M in Q4 2020.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Belpointe Asset Management's 13F filing for Q1 2026, filed 28 Apr 2026.